Navigation Links
Last chance for media to pre-register for Europe's largest cancer congress: ECCO15-ESMO34
Date:9/11/2009

ECCO 15 ESMO 34 will take place at the ICC Berlin Internationales Congress Centrum, Messedamm 22, D-14055 Berlin, Germany (www.icc-berlin.de) from Sunday 20 September to Thursday 24 September 2009.

This is your last chance to pre-register to attend the congress. After Tuesday 15 September, you will have to register on-site in Berlin.

The first press conference will be held on Sunday 20 September at 16.00 hrs (CEST).

Registration

ECCO 15 ESMO 34 is open to bona fide representatives of print, electronic and broadcast media. For further details and media registration, go to: http://www.ecco-org.eu/Conferences-and-Events/ECCO-15-ESMO-34/page.aspx/216

NB: Media registration in advance is strongly recommended.

Press conferences and webcasts

There will be media news briefings at the following times:
Sunday 20 September, 16.00 hrs (CEST) in English (embargoed to Monday)
Monday 21 September, 11.00 hrs (CEST) in German
Tuesday 22 September, 11.15 hrs (CEST) in English
Wednesday 23 September, 11.15 hrs (CEST) in English

For journalists unable to attend the congress, all press conferences will be broadcast live by the open access journal ecancermedicalscience (http://www.ecancermedicalscience.com/), the ECCO15 ESMO34 official media partner. They will also be available to view on demand approximately one to two hours after the end each press conference.

Press conferences will be available to watch live to media only.

NB: you need to register in advance to watch the webcasts.

Register here in advance to access the daily webcasts: http://www.ecancermedicalscience.com/pressconference

If you have any questions regarding viewing the conferences please contact: jonathan@ecancermedicalscience.com

Here is a sample of the news results to be announced at the congress (embargoed to time of presentation at ECCO15-ESMO34):

  • New blood tests promise simple, cost-effective diagnosis of gastrointestinal cancers.
  • Can aspirin prevent cancer in people with an inherited predisposition to colon cancer? International clinical trial has the answer.
  • Surgical removal of primary tumour improves survival in metastatic breast cancer patients.
  • Genetic identification of patients who are hypersensitive to radiotherapy helps improve treatment and avoid side-effects.
  • Potentially practice-changing results of phase III trial combining targeted heat therapy with chemotherapy in locally advanced soft tissue sarcoma.
  • Largest and most comprehensive study to date investigates links between prostate cancer hormone therapy and heart disease.
  • Largest study to date investigates the effect of whole-brain radiotherapy in patients with limited spread of primary cancer to the brain.
  • Meta-analysis clarifying the impact of adding cetuximab to various chemotherapy combinations in advanced non-small cell lung cancer.
  • Expert calls for new cancer research priorities and outlines strategy to cope with growing burden of cases.
  • Significant advances made in treatment of malignant melanoma: two trials show improvements in overall survival and rapid shrinking of tumours.
  • New results from SOLTI randomised trial on use of sorafenib in combination with chemotherapy in advanced breast cancer.
  • Could HPV vaccination and screening eradicate cervical cancer?
  • New figures on the numbers of new cancers in Europe caused by excess body fat.
  • Pancreatic cancer: researchers find drug that reverses resistance to chemotherapy.
  • New research on ultrasound shows it can predict tumour burden and survival in melanoma patients, sparing unnecessary surgery.
  • Innovative test for new cancer drugs will lead to quicker validation and safer and more efficient clinical trials.
  • Keep taking the medicine: study of adjuvant endocrine treatment for breast cancer reveals the cost of patient non-compliance.
  • Switching early breast cancer patients to exemestane improves long-term survival.
  • Findings of the first study of teen experiences during the process of obtaining a cancer diagnosis.


'/>"/>

Contact: Emma Mason
wordmason@mac.com
44-771-129-6986
ECCO-the European CanCer Organisation
Source:Eurekalert

Related biology news :

1. Last chance for media to register for ECCO 14 -- the European Cancer Conference
2. Age increases chance of success as two-timer
3. UV light improving chances of fighting cancer
4. Research forecasts increased chances for stormy weather
5. TB bacterium uses its sugar coat to sweeten its chances of living in lungs
6. New CU-Boulder study shows diversity decreases chances of parasitic disease
7. Blood test predicts chance of dementia
8. Work of Field Museum scientist addresses question of chance in evolution
9. They are young and need the job: A second chance for dangerous T-cells
10. September Geology and GSA Today media highlights
11. Heart of Herschel to be presented to media
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/2/2016)... NEW YORK , Feb. 2, 2016 ... healthcare facilities are primarily focused on medical ... that measure point-of-care parameters. Wearable devices that ... a user,s freedom of movement are being ... sensors for human biomedical signal acquisition coupled ...
(Date:2/2/2016)... Feb. 2, 2016   Parabon NanoLabs ... U.S. Army Research Office and the Defense Forensics ... sensitivity of the company,s Snapshot Kinship Inference ... and, more generally, defense-related DNA forensics.  Although Snapshot ... (predicting appearance and ancestry from DNA evidence), it ...
(Date:2/1/2016)... , Feb. 1, 2016  Wocket® smart wallet ( www.wocketwallet.com ) announces ... personality, Joey Fatone . Las Vegas , ... --> Las Vegas , where Joey appeared ... The new video ad was filmed at the Consumer Electronics Show ... the Wocket booth to meet and greet fans. ...
Breaking Biology News(10 mins):
(Date:2/4/2016)... ... February 04, 2016 , ... ... takes place February 5-6 at the University’s student center, Kehr Union, located ... as workshops and competitions for ample networking, learning and collaborating opportunities. , ...
(Date:2/4/2016)... , Feb. 4, 2016 ContraVir Pharmaceuticals, ... on the development and commercialization of targeted antiviral therapies, ... & Investor Conference 2016, to be held February 8-9, ... Capital Group,s 2016 Disruptive Growth & Healthcare Conference, taking ... February 10-11, 2016. James Sapirstein , Chief ...
(Date:2/4/2016)... , ... February 04, 2016 , ... Many of the ... over 10 years. What sets them apart from other cuvette manufacturers is their ... on their website. On top of this steady flow of inside information, they ...
(Date:2/3/2016)... and HOLLISTON, Mass., Feb. 3, 2016 /PRNewswire/ ... HART ), a biotechnology company developing bioengineered organ ... and bronchus, today announced that CEO Jim ... CEO & Investor Conference on Tuesday, February ... New York City . HART,s presentation ...
Breaking Biology Technology: